Edition:
India

Arena Pharmaceuticals Inc (ARNA.OQ)

ARNA.OQ on NASDAQ Stock Exchange Global Select Market

56.95USD
20 Aug 2019
Change (% chg)

-- (--)
Prev Close
$56.95
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
193,790
52-wk High
$64.48
52-wk Low
$31.98

About

Arena Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing small molecule drugs across a range of therapeutic areas. The Company has three primary investigational clinical programs: etrasimod (APD334) in Phase II evaluation for ulcerative colitis, APD371 entering Phase II evaluation for the... (more)

Overall

Beta: 1.43
Market Cap(Mil.): $3,075.33
Shares Outstanding(Mil.): 49.57
Dividend: --
Yield (%): --

Financials

Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates